50242-921 : Hemlibra 150 mg/ml Subcutaneous Injection, Solution
| NDC: | 50242-921 |
| Labeler: | Genentech, Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Hemlibra |
| Dosage Form: | Subcutaneous Injection, Solution |
| Application #: | BLA761083 |
| Rev. Date: |
NDC Package Codes:
- 50242-921-01: 1 VIAL, SINGLE‑USE IN 1 CARTON (50242‑921‑01) > .4 ML IN 1 VIAL, SINGLE‑USE
Active Ingredients:
- Emicizumab
Dosage Strength:
- 150 mg/mL
Related Products:
Based on records with the same trade name.- 50242-920 Hemlibra 30 mg/ml Subcutaneous Injection, Solution by Genentech, Inc.
- 50242-922 Hemlibra 150 mg/ml Subcutaneous Injection, Solution by Genentech, Inc.
- 50242-923 Hemlibra 150 mg/ml Subcutaneous Injection, Solution by Genentech, Inc.
- 50242-927 Hemlibra 12 mg/.4ml Subcutaneous Injection, Solution by Genentech, Inc.
- 50242-930 Hemlibra 300 mg/2ml Subcutaneous Injection, Solution by Genentech, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 50242-920Next: 50242-922 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.